학술논문

A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen.
Document Type
Article
Source
Journal of Drug Assessment; Dec2022, Vol. 11 Issue 1, p1-11, 11p
Subject
LYMPHOPROLIFERATIVE disorders
CARDIOTOXICITY
CANCER chemotherapy
ALKYLATING agents
CHILD patients
DOXORUBICIN
Language
ISSN
21556660
Abstract
Copyright of Journal of Drug Assessment is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)